Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report

RATIONALE: Immune checkpoint inhibition has dramatically altered the therapeutic landscape in the treatment of a range of locally advanced and metastatic skin cancers. In particular, the treatment of metastatic melanoma with combined anti-programmed cell death protein 1 (anti-PD1) and anti-cytotoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Langan, Ewan A., Budner, Kaja, Zillikens, Detlef, Terheyden, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078305/
https://www.ncbi.nlm.nih.gov/pubmed/33879687
http://dx.doi.org/10.1097/MD.0000000000025513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078305/
https://www.ncbi.nlm.nih.gov/pubmed/33879687
http://dx.doi.org/10.1097/MD.0000000000025513

Ejemplares similares